Objective: Abstinance is not the only goal of the current drug addiction treatment modalities. New modalities focus rather on improvement in physical and mental health, personal and social functionality.
INTRODUCTION
Opiate addiction, which is caused by continuous and sustained use of opiates despite the significant adverse consequences, is a set of behavioral, physiological, and cognitive symptoms. Opiate addiction can lead to significant health and social problems. Opiate use is found to be associated with increased rates of HIV, hepatitis, and somatic and psychiatric complications including depression, suicidality, and antisocial behavior 1, 2 . The number of people using opiates at least once in the world is reported to be five million. In our country, according to data obtained from inpatient addiction treatment centers, the number of inpatient admissions were 5,214 in 2011. In 2011, 66% of inpatients were treated for heroin addiction 3, 4 . Opioid maintenance treatment is the most effective treatment for opiate dependence and is increasingly used 5, 6 . It has been demonstrated that maintenance treatment in heroin use has clinical benefits such as the reduction of risky behaviors, improvement in health status, and withdrawal from social and legal problems [7] [8] [9] . The main objective of opiate addiction treatment is a reduction or cessation of illicit opioid use. However, it is necessary to make a follow-up to these areas to assess the changes with treatment in the impairment in psychological, social, and medical areas caused by dependence 10 . The measure of the change in functionality and quality of life is increasingly used to assess the effects of care provided to patients with chronic disorders 11, 12 . Buprenorphine has less side effects compared to other drugs used in the substition treatment (methadone, etc.) but also its efficacy is similar to them 13, 14 . Its potential advantages depends on its pharmacological properties. Buprenorphine is a partial mu agonist and kappa antagonist, therefore it causes to less euphoria and depression compared to metadone which is a full mu agonist 15 . There are only two types available in the market including stand alone form and combined form with naloxone. The combined BN sublingual tablets, which is the only available alternative opiate maintenance treatment in Turkey, were used. Accelerated withdrawal risk is extremely low in combined use, because bioavailability of naloxone is bad when administered as sublingual. Despite low sublingual bioavailability of naloxane, its parenteral bioavailability is high. So parenteral use of naloxone can lead to opiate withdrawal in people with opiate dependent 16 . Thus, combined tablet reduces the likelihood of parenteral abuse of buprenorphine.
Although there is data obtained from a few randomized clinical trials related to overall effectiveness of BN tablets in the treatment of opiate dependence, there is relatively limited study related to efficiency and reliability of the maintenance treatment which reflects real world conditions 17 . Also, there are fewer studies which were reported the efficacy of BN on opiate dependence in Turkey 18, 19 . In this study, we aimed to determine the efficacy of BN maintenance therapy in patients with opiat dependence by evaluating the rate of treatment continuation, the perceived stress level, functionality, craving, and quality of life. Our hypothesis was that BN maintenance treatment in opiate dependence would decrease the level of craving, perceived stress level, and reduce the use of illegal substance. In addition, it will provide a significant improvement in the quality of life and functionality.
METHOD
The study was performed in Istanbul University, School of Medicine, Department of Psychiatry Inpatient Services on the patients with opiate d e p e n d e n c e w h o w e r e a d m i n i s t r a t e d detoxification treatment at inpatient clinic and made follow-up exams at the outpatient dependency clinic after discharging.
The study which were designed as pretest, last test, and repeated measure was conducted on the the patients with opiat dependence according to DSM-IV who were hospitalized in psychiatric ward at the time between June 2012 and December 2012, were from 18 to 65 years old and have signed the informed consent as voluntarily. Pregnant, illiterate, breastfeeding, and patients with psychotic disorders were excluded from the study. At the time of the study, of 53 hospitalized patients with a diagnosis of opioid dependence, 2 were excluded from the study because they refused to participate in the study, when one patient was excluded due to illiteracy. The patients who agreed to participate to the study were undergone a baseline interview and evaluation by a training research asistant at inpatient clinic, other interviews (3 rd and 6 th month) were made at our outpatient clinic. The study protocol was reviewed and approved by the Institutional Review Board of Istanbul University, Faculty of Medicine.
The stress variable was measured by using the Perceived Stress Scale; medical condition, business support status, drug and alcohol use, legal status, family and social relationships, and psychiatric status were measured by using ASS; craving level was evaluated by using VAS; and the measurement associated with the quality of life was obtained by using SF-36. In addition, participants who continued to the treatment were administrated a substance screening in the urine.
Perceived Stress Scale (PSS): Perceived Stress Scale (PSS) is a measure scale developed by Cohen et al. 20 . In the scale used frequently, administrator wants individuals to rate certain feelings or thoughts whom they experienced in the past month (from 0 [never] to 5 [very often]). Perceived stress level is determined by collecting the scores of the items and high scores indicate high levels of perceived stress. Turkish adaptation of Perceived Stress Scale was performed and it has been reported that it has adequate internal consistency and criterion validity 21 . 
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Visual Analog Scale (VAS):
The visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. The authors administered this instrument on which the patient reports his or her level of subjective craving. The question that is used in the instrument "How strong is your craving for heroin?". The patient then rates his or her craving either by selecting the most appropriate choice by indicating a position along a continuous line between two end-points (Scale=0-100; 0= not at all; 100=very much so). This continuous (or "analogue") aspect of the scale differentiates it from discrete scales such as the Likert-type scale. There is evidence showing that visual analogue scales have superior metrical characteristics than discrete scales, thus a wider range of statistical methods can be applied to the measurements 23, 24 . 25, 26 .
Quality of Life
Statistical Analysis
The rates of retention and compliance in the treatment were evaluated. Nineten patients completed six month treatment period. The rate of retaining in the treatment was 52% in the 3 rd month, the rate of patients who were still in treatment decreased to 38% at the end of the 6th month. However, all patients have been evaluated by using the last observation carried forward (Last Observation Carried Forward/ LOCF) method in order to objectively measure the effect of treatment 27 . LOCF is a method used especially in the longitidunal studies. In this method, data loss would be filled by the appointment of the last observed value before the loss instead of missing values. In this method, the previous data complete the place of the next missing data.
Statistical analysis was performed by using SPSS 19.0 statistical package program. We used descriptive statistics to describe patient characteristics at the baseline. The patients' scores of Visual Analog Scale (VAS), the Perceived Stress Scale (PSS), Addiction Severity Scale (ASI) and the SF-36 scale on the baseline, 3 rd and 6 th months time points were compared by using ANOVA test method for repeated measurements. p values less than 0.05 were considered significant (p<0.05).
RESULTS
Socio-demographic data of the patients was presented in Table 1 . Substance screening in urine was found positive at least once on sixteen patients who came to follow up (approximately one third of all patients ). Of patients with positive urine screen, six had positive in only opiate, four had only benzodiazepine, three had only cannabis positive and three patients experienced positive results in screening of both opiates and cannabis, whereas opiates and benzodiazepines were found positive in only one of them. Of 16 patients, 9 (56%) completed six months of treatment. The patients who had positive urine result for cannabis could not complete the treatment at the end of sixth month, whereas five patients with only opiat positive in the urine and four patients with benzodiazepine and opioid positive completed the maintanance treatment. According to ANOVA results which compared the patients' scores of VAS at the baseline, third and sixth months in repeated measurements, there was a significant statistical difference between the time points (Table 2 ). According to multiple comparison test results, significant differences were found between the scores of VAS-beginning and VAS-3 rd month (p<0.01) and the scores of VAS beginning and VAS-sixth month (p<0.01). VASbeginning points were greater in both conditions (Table 2) .
There was a significant statistical difference between the time points, when evaluating ANOVA results which compared the patients' scores of PSS at the beginning, third and sixth months in repeated measurements (Table 3) . In order to find this difference from which time points derived, multiple comparison test was made. According to this, significant differences were found between, PSS-Baseline with PSS-third month (p<0.01) and the scores of PSS at baseline and PSS at 6 th month (p<0.01). PSS-Baseline scores were higher in each case (Table 3) .
According to ANOVA results which compared the patients' scores of SF-36 at the beginning, third and sixth months in repeated measurements, there (Table 4) . In order to find these differences from which time points derived, multiple comparison tests were made. According to test results, significant differences were found between the scores of baseline and third month (p<0.01) and between the scores of baseline and sixth month (p<0.01) in all subscales of SF-36 except of General Health dimension. In General Health dimension, significant differences were ASI at the baseline, third and sixth months in repeated measurements, there were significant statistical differences between the time points in the scores of ASI-"Business and Support Status" composite and severity, "Legal Status" severity, "Alcohol and Drug Status" composite and severity, "Family and Social Relationships"composite and severity and "ASIpsychiatric status composite and severity (p<0.001). Multipl comparison tests revelaed found only between the scores at baseline and sixth month. According to ANOVA results which compared the patients' scores of that significant differences were found between the scores at baseline and third month (p<0.01 ) and between the scores at baseline and sixth month (p<0.01 ) in all subscales of ASI except of "Business and Support Status" composite score. In the Business and Support Status" composite score, significant differences were found only between the scores at baseline and 6 th month (p<0.001). When evaluated all patients, significant improvement was observed in all areas of ASI except of "Medical Status" subscale at the end of sixth month (Table 5) .
DISCUSSION
In this study, the effects of the BN maintenance treatment in opiate-dependent patients on the quality of life, functionality and the status of substance use were examined longitudinally. It is important to note that this is the first prospective study which assessed the effects of BN treatment on the quality of life in patients from Turkey. The significant decrease on the substance craving level, illicit drug use, stress level and the significant improvement of the quality of life in almost all areas and functionality were found.
In our study, the rate of retaining in the treatment was 52% in the 3 rd month, BN treatment was to be found to reduce to 38% at the end of the 6 th month. It is widely accepted that this syndrome is a chronic disorder characterized by recurrence (relapse), slip (lapse) and the recovery (in remission). It is seen that recurrences are frequent in the opiate dependence treatment made with classical purification and psychosocial methods. It is shown that two thirds of the recurrences usually occur in the first three months. On the other hand, it is known that most patients receiving opioid agonist treatment can remain completely or partially away from the substance. It is reported that only 20-30% of the patients on this treatment continued to use heroin regularly. However, after leaving the agonist maintenance treatment, a return to heroin use is common and there is not enough research data about in who, when and how to cut this treatment 28 . It is estimated that more than 50% of the patients either left or were removed from treatment in the first three weeks of the treatment 29 . In one study, the rate of retention in treatment at the end of four months of the opiate dependent patients in buprenorphine maintenance treatment is reported 45% 15 , in another study, the rate of retention in treatment at the end of six months is reported 79% 30 . Evren et al. recently reported that the rate of retention was 26.8% at the end of sixth month in their study from Turkey. In our study, the rate of retention in treatment at the end of six months has been determined to be at 38%. In the literature screening, we noticed that there were both similar results to our study and different results from our study. In maintenance treatment of opiate dependence, in addition to medical maintenance therapy, provision of Cognitive Behavioral Therapy (CBT), weekly group therapy sessions and minimum psychosocial interventions including family training intervention when necessary are convenient. The quality of the offered additional services considerably affects the effectiveness of opiate maintenance therapy 16 . In our study, a low rate of retention in treatment, compared to some studies, may be associated with additional services offered. On the other hand, approximately one third of the patients who came to follow during treatment (n=16) the substance screening in urine was positive in the present study. If these patients were excluded because of determining one illicit substance in urine, they would fail the treatment. However, 9 of the 16 patients (56%) successfully completed the 6 months of treatment. During the treatment, the rate of illicit drug use markedly decreased. These results are similar to findings in the literature 31, 32 . On the other hand, Evren et al. 47 found that most of the patients that used illicit BN had done this before their monitored use of BNX and had used it to relieve withdrawal symptoms. So that, they suggested that the main difficulty for those seeking illicit BNX in Istanbul is how to access treatment. In our study, substance craving degrees of the patients were measured once a month. When the points of VAS at the beginning, 3 rd month and 6th month were compared, a statsistically significant decrease on the degree of substance needs was detected. It is reported that the replacement or maintenance treatment (buprenorphine, methadone, LAAM) reduced the substance need 33 . Apelt et al. 17 reported that at the beginning of the treatment, the substance need was highest in opioid-dependent patients who they follow with the BN treatment. They reported the most significant decrease in opiate need at the end of the 12-month treatment period with BN. Decrease of the opiate need was reported to be significant for all groups including those who didn't complete the study 17 . In another study, in opioid-dependent patients followed by buprenorphine/ naloxone maintenance treatment, the severity of the substance need was evaluated by using heroin craving to scale at the start, the first, third and sixth month of treatment. The need for heroin patients showed very significant decrease from the first month and it was reported that this reduction continued for six months 34 . In our study, it is determined that the initially perceived stress level of the patients significantly decreased with the maintenance treatment. Ponizovsky et al. 30 notified that there is a significant positive effect on self-efficacy of buprenorphine in parallel a significant decrease in psychological stress during follow-up study they do in opioiddependent patients. In the studies, a positive correlation between the stress and the opiate use during and after the treatment was reported. The first, third and sixth months of stress and anxiety levels of a group of opioid-dependent patients followed by BN maintenance treatment were examined at the beginning of the treatment with STAI and the Hamilton Anxiety Scale and a significant decrease was confirmed in stress and anxiety levels 34, 35 . In addition, Evren et al. 46 suggested that impulsiveness and state anxiety may be the areas to focus on in the treatment of relapsed heroin dependents. In our study, in all subscales of SF-36 scale which we evaluated the life quality at the end of the 6 th month positive developments were identified. Our findings indicate that BN maintenance treatment provides positive changes in life quality of the opioid-dependent patients. In a study which is done by using the Lancashire Quality of Life Profile Scale, in a group of 30 opiate-dependent patients who completed 24 weeks of treatment with buprenorphine there were significant improvements in life quality scores36. In the study where Raisch et al. 15 followed opioid-dependent patients with buprenorphine maintenance treatment for a total of 16 weeks, only 45% of 96 patients completed 16 weeks of treatment. To carry out the treatment analysis, the final value was used assuming the last life quality (SF-36) scores of the patients who dropped out the treatment before 16 weeks wouldn't change even though they continue. The SF-36 scale scores, when they are compared with the beginning, during the treatment significant improvements were detected in size of Life Quality (SF-36) Role limitations (due to physical and emotional problems), social function, mental health, vitality (energy / fatigue) and pain; but there was no significant improvement in physical function and general health 15 . In the study, Korthuis et al. 37 , started BN treatment in 303 HIV (+) opioid-dependent patients in the scope of study and the participants were examined SF-12 Short Form Quality of Life Scale. The average s c o r e s i m p r ov e d f o r p s y c h i a t r i c f a v o r subcomponents. The Average combined physical size score didn't improve significantly over time but patients reported improvements in general health size and physical role function.The fact that most of the improvement in quality of life scores occurred in the first three months of BN and then continued during the entire follow-up period was confirmed 37 . Apelt et al. 17 followed 244 treated opioid-dependent patients and 49 not treated opioid-dependent patients for 12 months with the BN treatment and at the outcome assessment, they proved that the ones who completed the treatment have significantly higher scores at all scales and the ones who didn't complete showed insignificant improvement from start to final assessment 17 . The results of our study support the findings of the literature and it is important as it is the first study showing the positive impact on life quality of the opiate maintenance treatment in our country.
In our study, the BN treatment provided a significant improvement in the functionality evaluated with ASI and most of these developments became clear in first three months and continued for six months. It is notified that Opioid maintenance treatment decreases death rates, drug use, bad results of opiate dependence, criminal behavior and blood-borne diseases; improves social functioning, physical and mental health and increases retention in treatment and employment rates [38] [39] [40] . In a study, the recovery in five of the six dimensions of ASI (Alcohol-Drug Use, Medical Conditions, Legal Status, Family Status, social relations and psychiatric status) of 80 opiate-dependent patients followed by BN maintenance treatment, excluding businesssupport case dimension of ASI, when considered with the beginning, first third and sixth month, was reported 34 . In a study conducted in our country, in a group of patients who continued the BN maintenance treatment, improvements on business-support, family and social relations, psychiatric, alcohol and substance cases of the patients were detected but no changes were detected in their medical and legal status 41 . In our study, in the functionality evaluated with ASI, a positive development was found in all other areas excluding the medical conditions and business-support status compound score. To not observe any improvement in general medical condition can be explained by the fact that the medical condition at the beginning of the patients wasn't usually too bad and their other diseases (Hepatitis B, Hepatitis C, Coronary Artery Disease, etc.) were chronic. In ASI businesssupport status compound score, the nonbeing of any improvement between the beginning and the sixth month can be related with the item of income level in the scale. In some patients engaged in the sale of illegal substances, a decrease in their gain occurred as they stopped selling when they stopped using it.
In the present study, after the maintenance treatment of patients, it is noteworthy that there was a significant reduction in legal status severity scores. In other studies, the successful completion of the treatment of the heroin dependants brings decreasing arrest rates, less crime and less time in prison for them [42] [43] [44] . But there are also studies indicating no relationship between treatment and offenses. In a study, it was reported that treatment and control did not affect the probability of recidivism of the substance dependents under supervision 45 . Before the conclusions the present study's limitations must be considered. Firstly, our sample size was smaller when comparing to other studies in the literature. VAS scale using to measure the level of craving in this study was not adapted and validated for use in Turkey.
CONCLUSION
Despite above mentioned limitations, our study underlines the overall effectiveness of BN maintenance treatment in opiate-dependant patients. Our results show that substance desiring, illegal drug use, and stress level significantly decreased and the life quality and functionality significantly improved with the treatment. In the six-month observation period, there were significant improvements in almost all assessed areas and the change was more apparent in the first three months of the process and continued for six months.
